CO-VAC-01

E-POSTERS Integration of vaccination schemes based on TS and TcTASV antigen families developed by two Argentine groups: Potential improvement in protection against challenge with two Trypanosoma cruzi strains

VAC-06

E-POSTERS UTILIDAD DE LAS PROTEÍNAS INHIBIDORAS DEL COMPLEMENTO DE TRYPANOSOMA CRUZI COMO ANTÍGENOS VACUNALES: UN ANÁLISIS BIOINFORMÁTICO

VAC-04

E-POSTERS Evaluación de Candidatos Vacunales contra Trypanosoma vivax basados en Proteínas de Superficie

VAC-03

E-POSTERS Evaluación de una nueva plataforma vacunal empleando Crithidia fasciculata recombinante como sistema delivery de antígenos

VEC-20

E-POSTERS Modelos compartimentales para la dinámica de los ciclos de transmisión de Leishmania braziliensis y Magnivitellinum saltaensis

VAC-10

E-POSTERS ISPA Cage-Like Particle Adjuvant Enhances Immune Responses of Recombinant Proteins in Vaccine Formulations Against Chronic Toxoplasma gondii Infection in Mice

VAC-08

E-POSTER Evaluation of a prophylactic vaccine candidate for Chagas disease composed of multicomponent antigens carried by live Lactobacillus acidophilus ATCC 4356 cells

VAC-07

E-POSTER Evaluation of dose number impact on immunogenicity and efficacy of a DNA-launched RNA replicon vaccine candidate against Trypanosoma cruzi infection

VAC-02

E-POSTER Leishmania pyruvate kinase and mitochondrial processing protease: Two novel vaccine candidates, selected using a seroproteomic approach, triggered a protective immune response against murine cutaneous leishmaniasis

VAC-05

E-POSTER Towards enhancing vaccination efficacy against T. cruzi: Understanding the mechanism of a new antigen, N-Tc52/TSKb20